Cystatin C is associated with adverse COVID-19 outcomes in diverse populations.
iScience
; 25(10): 105040, 2022 Oct 21.
Article
in En
| MEDLINE
| ID: mdl-36062073
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
IScience
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos